Skip to main content
Signal8
Fuchs Thomas profile photo

Thomas Fuchs

CIK: 0002083937

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GeneDx Holdings Corp. logo
WGS

GeneDx Holdings Corp.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • GeneDx Holdings Corp. logo
    WGS

    GeneDx Holdings Corp.

    Sep 17, 2026
    Exercise(M)
    Direct
    1.1K shares-
  • GeneDx Holdings Corp. logo
    WGS

    GeneDx Holdings Corp.

    Jun 18, 2026
    Award(A)

    Restricted Stock Unit

    Direct
    4.2K shares-
  • GeneDx Holdings Corp. logo
    WGS

    GeneDx Holdings Corp.

    Sep 17, 2025
    Award(A)

    Restricted Stock Unit

    Direct
    3.4K shares-

1-3 of 3

About Fuchs Thomas

Fuchs Thomas (SEC CIK 0002083937) files insider reports with the SEC as Director of GeneDx Holdings Corp. (WGS).

Signal8 holds 4 ownership filings by Fuchs Thomas (1 Form 3, 3 Form 4), filed between Sep 19, 2025 and Sep 18, 2026. Those filings report 3 transactions, from Sep 17, 2025 to Sep 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Fuchs Thomas's filings is in STAMFORD, CT.

Recent filings by Fuchs Thomas

  • Sep 17, 2026: Option exercise of WGS shares (Form 4, code M).
  • Jun 18, 2026: Grant or award of WGS derivative securities (Form 4, code A).
  • Sep 17, 2025: Grant or award of WGS derivative securities (Form 4, code A).

Other insiders filing for GeneDx Holdings Corp. (WGS)

How to read Form 4 transaction codes